about
Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors.Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer PropertiesIn Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach.Population pharmacokinetic/pharmacodynamic modelling of the effects of axomadol and its O-demethyl metabolite on pupil diameter and nociception in healthy subjectsIn vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Commentary on the MID3 Good Practices Paper.A promising camptothecin derivative: Semisynthesis, antitumor activity and intestinal permeability.Population pharmacokinetic model of lithium and drug compliance assessment.Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivatives.Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets.Drug gastrointestinal absorption in rat: Strain and gender differences.Semimechanistic cell-cycle type-based pharmacokinetic/pharmacodynamic model of chemotherapy-induced neutropenic effects of diflomotecan under different dosing schedules.Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid.Validation of a semi-physiological model for caffeine in healthy subjects and cirrhotic patients.Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat.Enhancing Oral Absorption of β-Lapachone: Progress Till Date.Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter.IVIVC approach based on carbamazepine bioequivalence studies combination.Modified nonsink equation for permeability estimation in cell monolayers: comparison with standard methods.Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles.Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.Investigating the Discriminatory Power of BCS-Biowaiver in Vitro Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class I Drug.Ion-pair strategy for enabling amifostine oral absorption: rat in situ and in vivo experiments.Systematic modelling and design evaluation of unperturbed tumour dynamics in xenografts.Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation.Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfateComparison of free software platforms for the calculation of the 90% confidence interval of f2 similarity factor by bootstrap analysisAssessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of EquivalenceTopiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedulePharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular DegenerationA multilevel object-oriented modelling methodology for physiologically-based pharmacokinetics (PBPK): Evaluation with a semi-mechanistic pharmacokinetic model
P50
Q34994529-A7C240F1-D3D8-4FD4-9765-52B5699D416AQ35961028-314BAC1E-85BF-4034-B402-48D9289BCA4FQ36088290-245BA717-ED27-4CEA-8BB9-1E335B27C0E1Q37030723-6918A6AB-6751-402E-A6F2-6F2518E54BCCQ38541574-B65280E3-15B9-4C4F-BBAD-42247F601EBBQ38707591-0B699B52-FCDF-40F7-BAC2-97C3023A0A5AQ38979581-5A1FA23D-78A9-496F-879B-1B9441EBF295Q39171975-CBF87C83-E561-4DC8-B683-0E0AC90BC521Q39777927-20EA9FE4-DE52-49DE-A0DC-07FE9C3E7489Q40665911-AB925C6E-D0D5-4BC4-8230-C6CEC7ACAB9EQ40678840-3AFCDE6E-9F4B-44D7-A2AE-48B233C5BE3BQ40967654-9BFE22C9-9042-4649-BB21-1725224854F7Q41079136-AF1DAC0C-4107-4B31-A7DA-5B439E2DE231Q41114594-FA999A6E-1885-4BCF-83E4-E6FF081D2B3AQ45893532-0AD70165-1B55-4180-99DB-695D963EF92FQ48432760-0872F5B8-1027-4C1A-B0B2-59946ACC174EQ49108416-EA17083D-4A55-45DC-B3F7-89085070CFD7Q49923140-AED785A7-DA67-4067-AE2A-B86A1CFCA03DQ50018496-44199239-57E7-439D-B1A9-E15E2601EA56Q51099767-9E675300-9B02-4D6A-B649-CA07B64F3657Q51109814-2C125237-1DC2-4CFB-B42D-64D4ECCE4959Q51631401-37D24AEF-40A9-4F2B-BDC2-2DE0159CAEE0Q51803073-E90FDF60-CB1D-4F42-8D07-0C416C402F29Q51814010-D5AB485F-395A-4EB7-BBED-F145507056F0Q52565559-8E25C56D-6234-4675-81DB-F2EBDCE6144CQ52572372-E94A0EDF-D44E-4DFE-9BB8-2F293579DEE5Q53795637-0DB3BFEE-AADE-4BE6-93E5-8650070F64B7Q84744607-F1319EC3-E198-4414-AB02-32EB456964C0Q89713858-69303A6E-1E9D-44DF-A958-CA2D598A2511Q90460278-D0D16460-35D2-4F94-AD0D-269286459045Q92125424-5E604586-C73D-49F9-8433-4D4E6F37E4A8Q92344685-13EB8804-8BE8-457F-BCBF-9D659BB9D7EAQ92745391-D320C330-25BF-4510-93D1-BE6D5A54C15E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Victor Mangas-Sanjuan
@ast
Victor Mangas-Sanjuan
@en
Victor Mangas-Sanjuan
@es
Victor Mangas-Sanjuan
@nl
Victor Mangas-Sanjuan
@sl
type
label
Victor Mangas-Sanjuan
@ast
Victor Mangas-Sanjuan
@en
Victor Mangas-Sanjuan
@es
Victor Mangas-Sanjuan
@nl
Victor Mangas-Sanjuan
@sl
prefLabel
Victor Mangas-Sanjuan
@ast
Victor Mangas-Sanjuan
@en
Victor Mangas-Sanjuan
@es
Victor Mangas-Sanjuan
@nl
Victor Mangas-Sanjuan
@sl
P108
P106
P21
P31
P496
0000-0002-2503-3373